U.S. flag

An official website of the United States government

NM_000576.3(IL1B):c.315C>T (p.Phe105=) AND Cholangiocarcinoma

Germline classification:
other (1 submission)
Last evaluated:
Dec 10, 2022
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003311942.3

Allele description [Variation Report for NM_000576.3(IL1B):c.315C>T (p.Phe105=)]

NM_000576.3(IL1B):c.315C>T (p.Phe105=)

Gene:
IL1B:interleukin 1 beta [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q14.1
Genomic location:
Preferred name:
NM_000576.3(IL1B):c.315C>T (p.Phe105=)
HGVS:
  • NC_000002.12:g.112832813G>A
  • NG_008851.1:g.8967C>T
  • NM_000576.2:c.315C>T
  • NM_000576.3:c.315C>TMANE SELECT
  • NP_000567.1:p.Phe105=
  • NC_000002.11:g.113590390G>A
Links:
dbSNP: rs1143634
NCBI 1000 Genomes Browser:
rs1143634
Molecular consequence:
  • NM_000576.3:c.315C>T - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Name:
Cholangiocarcinoma
Identifiers:
MONDO: MONDO:0019087; MeSH: D018281; MedGen: C0206698; Human Phenotype Ontology: HP:0030153

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004011737Department of Surgery, Campus Charité Mitte | Campus Virchow-klinikum, Charite-Universitaetsmedizin Berlin
no assertion criteria provided
other
(Dec 10, 2022)
germlineresearch

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedresearch

Citations

PubMed

Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer.

Lurje G, Zhang W, Schultheis AM, Yang D, Groshen S, Hendifar AE, Husain H, Gordon MA, Nagashima F, Chang HM, Lenz HJ.

Ann Oncol. 2008 Oct;19(10):1734-41. doi: 10.1093/annonc/mdn368. Epub 2008 Jun 11.

PubMed [citation]
PMID:
18550579
PMCID:
PMC2735064

Details of each submission

From Department of Surgery, Campus Charité Mitte | Campus Virchow-klinikum, Charite-Universitaetsmedizin Berlin, SCV004011737.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedresearch PubMed (1)

Description

C/C genotype associated with significantly shorter OS after surgical resection of intrahepatic CCA

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 16, 2025